RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Corix Bioscience P/E 2024

Corix Bioscience P/E

-10.11

Corix Bioscience Dividend yield

Ticker

CXBS

ISIN

US21887N1037

WKN

A14UX1

As of May 26, 2024, Corix Bioscience's P/E ratio was -10.11, a 0% change from the 0 P/E ratio recorded in the previous year.

The Corix Bioscience P/E history

Corix Bioscience Aktienanalyse

What does Corix Bioscience do?

Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Corix Bioscience's P/E Ratio

The Price to Earnings (P/E) Ratio of Corix Bioscience is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Corix Bioscience's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Corix Bioscience is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Corix Bioscience’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Corix Bioscience Stock

What is the price-to-earnings ratio of Corix Bioscience?

The price-earnings ratio of Corix Bioscience is currently -10.11.

How has the price-earnings ratio of Corix Bioscience changed compared to last year?

The price-to-earnings ratio of Corix Bioscience has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Corix Bioscience high compared to other companies?

Yes, the price-to-earnings ratio of Corix Bioscience is high compared to other companies.

How does an increase in the price-earnings ratio of Corix Bioscience affect the company?

An increase in the price-earnings ratio of Corix Bioscience would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Corix Bioscience affect the company?

A decrease in the price-earnings ratio of Corix Bioscience would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Corix Bioscience?

Some factors that influence the price-earnings ratio of Corix Bioscience are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Corix Bioscience pay?

Over the past 12 months, Corix Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Corix Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Corix Bioscience?

The current dividend yield of Corix Bioscience is .

When does Corix Bioscience pay dividends?

Corix Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Corix Bioscience?

Corix Bioscience paid dividends every year for the past 0 years.

What is the dividend of Corix Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Corix Bioscience located?

Corix Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Corix Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Corix Bioscience from 5/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/26/2024.

When did Corix Bioscience pay the last dividend?

The last dividend was paid out on 5/26/2024.

What was the dividend of Corix Bioscience in the year 2023?

In the year 2023, Corix Bioscience distributed 0 USD as dividends.

In which currency does Corix Bioscience pay out the dividend?

The dividends of Corix Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Corix Bioscience

Our stock analysis for Corix Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Corix Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.